{"product_id":"emideltide","title":"Emideltide DSIP","description":"\u003cp\u003eEmideltide is compounded Delta Sleep-Inducing Peptide (DSIP), a nine-amino-acid neuropeptide (sequence WAGGDASGE) first isolated in 1974 from cerebral venous blood during electrical stimulation of the thalamus and chemically synthesized in 1977. It is the same molecule the FDA docket refers to as \"Emideltide\" in the 2026 503A Bulks List review. Administered as a 1 mg subcutaneous injection 30 to 60 minutes before sleep, Emideltide crosses the blood-brain barrier intact and supports the body's own slow-wave generation while reducing ACTH-driven cortisol at night. It is not a sedative-hypnotic. It does not activate GABA-A receptors. Human trials report longer slow-wave sleep, preserved REM, no documented dependence, and no sedative hangover. Prescribed by a licensed clinician through async telehealth.\u003c\/p\u003e","brand":"IVUSE+","offers":[{"title":"Full Protocol","offer_id":51667486408992,"sku":"1400012","price":308.0,"currency_code":"USD","in_stock":true},{"title":"Single Vial","offer_id":51667480477984,"sku":"1400112","price":114.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0815\/7777\/1296\/files\/VialImageRecreation.webp?v=1782312761","url":"https:\/\/www.ivuseplus.com\/products\/emideltide","provider":"IVUSE+","version":"1.0","type":"link"}